Arizona State Retirement System increased its stake in shares of LivaNova PLC (NASDAQ:LIVN) by 1.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,300 shares of the company’s stock after buying an additional 300 shares during the period. Arizona State Retirement System’s holdings in LivaNova PLC were worth $1,120,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. FMR LLC boosted its position in shares of LivaNova PLC by 74.9% in the first quarter. FMR LLC now owns 4,817,815 shares of the company’s stock valued at $236,118,000 after buying an additional 2,063,196 shares in the last quarter. BlackRock Inc. boosted its position in shares of LivaNova PLC by 16,157.4% in the first quarter. BlackRock Inc. now owns 2,592,889 shares of the company’s stock valued at $127,077,000 after buying an additional 2,576,940 shares in the last quarter. State Street Corp boosted its position in shares of LivaNova PLC by 0.3% in the first quarter. State Street Corp now owns 1,050,160 shares of the company’s stock valued at $51,469,000 after buying an additional 2,913 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of LivaNova PLC by 4.5% in the first quarter. Vanguard Group Inc. now owns 777,356 shares of the company’s stock valued at $38,098,000 after buying an additional 33,645 shares in the last quarter. Finally, Credit Suisse AG boosted its position in shares of LivaNova PLC by 2,084.7% in the first quarter. Credit Suisse AG now owns 694,275 shares of the company’s stock valued at $34,026,000 after buying an additional 662,496 shares in the last quarter. Institutional investors own 82.36% of the company’s stock.

Shares of LivaNova PLC (NASDAQ LIVN) opened at 61.49 on Tuesday. The firm has a 50-day moving average price of $61.60 and a 200 day moving average price of $56.05. LivaNova PLC has a one year low of $40.83 and a one year high of $64.95. The firm has a market capitalization of $3.00 billion, a price-to-earnings ratio of 109.80 and a beta of 0.62.

LivaNova PLC (NASDAQ:LIVN) last announced its earnings results on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The firm had revenue of $321.40 million for the quarter, compared to analysts’ expectations of $315.75 million. The company’s revenue was up .1% on a year-over-year basis. Equities analysts forecast that LivaNova PLC will post $3.22 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/29/arizona-state-retirement-system-buys-300-shares-of-livanova-plc-livn.html.

LIVN has been the subject of several recent research reports. WBB Securities cut LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price target for the company. in a research report on Tuesday, August 15th. BidaskClub lowered LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Needham & Company LLC initiated coverage on LivaNova PLC in a report on Wednesday, August 23rd. They issued a “hold” rating on the stock. Finally, Berenberg Bank reissued a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a report on Friday, August 11th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. LivaNova PLC has a consensus rating of “Hold” and a consensus target price of $58.00.

In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $60.80, for a total transaction of $60,800.00. Following the sale, the director now owns 57,437 shares of the company’s stock, valued at $3,492,169.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last three months, insiders have sold 3,000 shares of company stock worth $183,110. 0.28% of the stock is owned by corporate insiders.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.